Tanvex BioPharma Inc
TWSE:6541

Watchlist Manager
Tanvex BioPharma Inc Logo
Tanvex BioPharma Inc
TWSE:6541
Watchlist
Price: 68.2 TWD 0.89% Market Closed
Market Cap: 11.2B TWD
Have any thoughts about
Tanvex BioPharma Inc?
Write Note

Tanvex BioPharma Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Tanvex BioPharma Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
688235
6550

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Tanvex BioPharma Inc
TWSE:6541
Cash & Cash Equivalents
NT$910.3m
CAGR 3-Years
-11%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Beigene Ltd
SSE:688235
Cash & Cash Equivalents
ÂĄ15B
CAGR 3-Years
33%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Polaris Group
TWSE:6550
Cash & Cash Equivalents
NT$3.6B
CAGR 3-Years
188%
CAGR 5-Years
56%
CAGR 10-Years
N/A

See Also

What is Tanvex BioPharma Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
910.3m TWD

Based on the financial report for Jun 30, 2024, Tanvex BioPharma Inc's Cash & Cash Equivalents amounts to 910.3m TWD.

What is Tanvex BioPharma Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-19%

Over the last year, the Cash & Cash Equivalents growth was -25%. The average annual Cash & Cash Equivalents growth rates for Tanvex BioPharma Inc have been -11% over the past three years , -19% over the past five years .

Back to Top